Announced Fri, 15 May · 18:25 IST

<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....

GKSL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+5.1%1-day move
₹136.99
prior close
₹140.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.5-2.1-2.2-1.4+5.1+2.2+1.5+4.5+2.7-0.9-5.5-6.3-7.3
Up moveDown movePending
AI summary

Gujarat Kidney and Super Speciality Limited has filed its annual disclosure with BSE and NSE confirming that it does not qualify as a Large Corporate (LC) under SEBI's Master Circular dated October 15, 2025. The disclosure covers the 2-year block period FY2025-26 and FY2026-27. Since the company is not classified as an LC, all mandatory borrowing requirements and incremental borrowing fields show NA. The filing is signed by the Company Secretary and CFO and submitted within the prescribed timeline.

Likely market impact

The company is not subject to SEBI's Large Corporate borrowing norms, which has no direct negative impact on shareholders. This is a routine compliance confirmation.